Access to payers is about knowledge, about understanding what they do in their jobs
ConvergeHEALTH by Deloitte has entered into a multi-year collaboration with Forest Labs and Intermountain Healthcare to conduct outcomes research.
The pharma market research major is working on unifying into one company with two main product lines, and is also in the process of a re-brand.
Should pharma formulate a super matrix to determine the FMV of research incentives?
The Affordable Care Act has spurred double-digit increases in demand for pharmaceuticals, new data suggest.
IMS Health raised $1.3 billion last month in its New York IPO.
Pharmaceutical companies must provide robust marketing support for their clinical trials
Researchers have developed and tested a checklist that aims to evaluate comparative effectiveness research and distinguish real-world studies that are good enough for decision-making about treatments.
Merck has broadened its analytics approach to include team-ups with a slate of organizations at the intersection of Big Data and health IT.
A new industry has emerged to provide analytics and predictive tools that support optimized care
National Pharmaceutical Council (NPC) said Eli Lilly joined earlier this year
Suppliers are touting a deeper level of analysis, in some cases bypassing the market-research function and reaching the highest levels of their pharma clients.
Pharma can be in the moment with customers as they interact with our information or products
The data and analytics giant is looking to launch an IPO. The company, which is the subject of an antitrust suit, said in its prospectus that it anticipates future acquisitions.
The regulator's proposed database could help identify adverse events.
Big Data is coming and with it the danger of pharmaceutical marketers relying on it too heavily
IMS Health brought market access firm HGS Europe into the fold last month.
In 2014, the "new healthcare marketing" will become more discontinuous from the old
When an FDA advisory panel met last month to vote on whether to recommend approval of Sanofi's MS drug Lemtrada, patient opinion leaders had already voiced their view.
The Centers for Medicare and Medicaid Services (CMS) unveiled a new research tool last month.
As I pull out my crystal ball, I see a day where we WANT to use secondary research first
The next generation of drugs sees a number of market access challenges
Eli Lilly is tapping Humana's claims database for therapeutic study
The American College of Cardiology (ACC) said it's entered an agreement to cull insights from a healthcare database
The first on-demand way to tap the influencer community in healthcare went live today, and results of a real-world test show it has the potential to accelerate the research process.
The partnership seeks to improve medication adherence through predictive analytics.
A quiet revolution is underway in research to keep pace with changes in medical marketing
Symphony Health Solutions filed an antitrust lawsuit against IMS Health, accusing it of trying to monopolize the pharma data and analytics market
The NIH said it will fund up to $24 million per year for four years to establish six to eight Big Data to Knowledge (BD2K) Centers of Excellence
The best-selling book "The End of Illness" illustrates an exciting new way to think of healthcare—and healthcare marketing research
Private equity firm Symphony Technology Group acquired several divisions of United BioSource Corp.
Memoto's tiny clip-on camera provides a detailed timeline of a patient's daily activities
For the client-side market researcher, "doing more with less" is a mantra, if not a corporate way of life
A study, offers for the first time, according to researchers, empirical evidence of the link between a company's culture from a commercial-operations standpoint and revenue performance.
Double-digit growth and a fragmented healthcare system in India have spurred consultancies and data firms, although experts say pricing for services varies widely.
For all the advances in technology and methodology, qualitative research cannot shed its history like its quant sibling
Athenahealth has wasted little time in putting its mark on Epocrates
Fiscal concerns are paramount in the rise of Big Data within healthcare, according to a recent McKinsey analysis, but clinical trends also play a role
"External drivers" can have a significant impact on determining the answer to your marketing question
Healthcare data and analytics giant IMS Health bought Seattle-based software-as-a-service (SaaS) company Appature.
New York University is forming a Center for Data Science, plus a master's-level degree program to prepare the next generation of data professionals
Marketing teams are not going to succeed in the future without a real understanding of the real world
"The marketing research community should be very satisfied with the additional guidance on the Sunshine Act from CMS," said the PMRG's government affairs committee chair
GSK Consumer Health Care is the newest member of a research organization that conducts experiments into how shoppers think and behave.
A foundational premise of agency-of-record and preferred-provider relationships has a fatal flaw
Pfizer and clinical data outfit Humedica jointly announced their intent to collaborate on studies examining the effectiveness of treatments.
Frank Lavelle officially became CEO of data and analytics provider Symphony Health Solutions in mid-January.
As it became evident that a large HCV+ cohort would likely need medical intervention, pharma responded
PatientsLikeMe, the online patient network and research platform, appointed Daphne Psacharopoulos to the new position of VP, client services and strategic initiatives
Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.